Section 1290.440  Recall of Medical Cannabis

a)         A dispensing organization must establish a policy for communicating a recall for cannabis or a cannabis-derived product that has been shown to present a reasonable or a remote probability that use of or exposure to the product will cause serious adverse health consequences. This policy should include:

1)         A mechanism to contact all patients, provisional patients, OAPP participants, and designated caregivers who have, or likely have, obtained the product from the dispensary.  The communication must include information on the policy for return of the recalled product;

2)         A mechanism to contact the cultivation center or vendor that manufactured the cannabis;

3)         Communication with the Division, DOA and DPH within 24 hours; and

4)         Outreach via media, as necessary and appropriate.

b)         Any recalled cannabis product must be disposed of by the dispensing organization.

(Source:  Amended at 43 Ill. Reg. 6593, effective May 20, 2019)